The Beauty Health Company SKIN Dilutive Securities Effect On Basic Earnings Per Share Other

Dilutive Securities Effect On Basic Earnings Per Share Other at other companies

NVE CorporationNVEC

$500.75-51.0%

Cineverse Corp.CNVS

-$0.01—

Trex CompanyTREX

$0.04—

REX American ResourcesREX

$0.56+115%

Evommune EVMN

-$0.36-1,700%

Cato CorporationCATO

18.8M+0.7%

Other financials

Income statement

See full

Revenue$64.9M-6.7%

Gross profit$44.4M-8.5%

Operating income-$1.8M+85.0%

Net income-$6.6M+34.3%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$204.4M-45.2%

Total debt$125.9M+756%

Total equity$55.2M+19.9%

Total assets$473.2M-29.8%

Cash flow

See full

Operating cash flow-$5.6M-285%

CapEx$224.0K+398%

Free cash flow-$5.8M-296%

Valuation

See full

Market cap$89.75M-61.5%

Enterprise value$11.24M-96.2%

P/S0.3×-0.4×

Profitability

See full

Gross margin64.9%+8.3pp

Operating margin-3.6%-1.6pp

Net margin-2%-0.9pp

FCF margin9.6%—

Returns & leverage

See full

Return on equity-12%-5.4pp

Debt / equity2.3×+2.0×

Current ratio1.8×-5.7×

Where this comes from

Reported directly by The Beauty Health Company in its filing.

Tagged under the XBRL concept us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther.

The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Beauty Health Company's dilutive securities effect on basic earnings per share other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is The Beauty Health Company's dilutive securities effect on basic earnings per share other?: The Beauty Health Company (SKIN) reported dilutive securities effect on basic earnings per share other of -$491K in Q1 2026.
What does dilutive securities effect on basic earnings per share other mean?: Measures the interest expense associated with debt instruments that have conversion features into equity. Monitoring this expense is critical for understanding the cost of capital and the impact of financing structures on the company's bottom line.